Immediate Impact
1 by Nobel laureates 6 from Science/Nature 60 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of William Larry Gluck being referenced
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
2019
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| William Larry Gluck | 167 | 109 | 39 | 152 | 22 | 394 | |
| David Sermer | 207 | 109 | 16 | 91 | 22 | 364 | |
| Marcin Pasiarski | 188 | 77 | 38 | 167 | 32 | 397 | |
| C B Freeman | 147 | 70 | 9 | 150 | 20 | 429 | |
| E D'Andrea | 109 | 147 | 36 | 116 | 22 | 397 | |
| Massimo Pini | 136 | 76 | 14 | 110 | 26 | 370 | |
| Mecide Gharibo | 193 | 169 | 46 | 49 | 33 | 386 | |
| Gabriel Brisou | 96 | 122 | 24 | 260 | 20 | 395 | |
| D Dantchev | 160 | 80 | 33 | 117 | 27 | 384 | |
| Klaus Lennartz | 103 | 183 | 54 | 116 | 23 | 426 | |
| J.M. Tourani | 126 | 63 | 62 | 80 | 17 | 375 |
All Works
Login with ORCID to disown or claim papers
Loading papers...